AstraZeneca (LON:AZN) Given “Buy” Rating at Jefferies Financial Group
AstraZeneca (LON:AZN – Get Free Report)‘s stock had its “buy” rating restated by Jefferies Financial Group in a note issued to investors on Friday,Digital Look reports. They currently have a £180 price target on the biopharmaceutical company’s stock. Jefferies Financial Group’s target price would suggest a potential upside of 26.12% from the company’s previous close. […]
26 Jun 15:24 · The Markets Daily